Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sverrir Vídalín Eiríksson"'
Autor:
Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson, Inna Markovna Chen
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 509 (2022)
The antitumor activity of chitooligosaccharides has been suggested. This phase 2 trial evaluated the efficacy and safety of T-ChOS™, in addition to adjuvant chemotherapy, in patients after resection of pancreatic ductal adenocarcinoma (PDAC). In th
Externí odkaz:
https://doaj.org/article/5a0346c68163424ea72e48cb40bd3697
Autor:
Theile, Susann1 (AUTHOR) julia.sidenius.johansen@regionh.dk, Johansen, Julia Sidenius1,2,3 (AUTHOR) dorte.nielsen.01@regionh.dk, Nielsen, Dorte Lisbet1,3 (AUTHOR) benny.vittrup.jensen@regionh.dk, Jensen, Benny Vittrup1 (AUTHOR) inna.chen@regionh.dk, Hansen, Carsten Palnæs4 (AUTHOR) carsten.palnaes.hansen@regionh.dk, Hasselby, Jane Preuss5 (AUTHOR) jane.preuss.hasselby@regionh.dk, Eiríksson, Sverrir Vídalín6 (AUTHOR) sverrir.vidalin.eiriksson@genis.is, Chen, Inna Markovna1 (AUTHOR)
Publikováno v:
Pharmaceutics. Mar2022, Vol. 14 Issue 3, p509. 13p.